透過您的圖書館登入
IP:3.145.42.128
  • 期刊
  • OpenAccess
  • Ahead-of-Print

以JAK抑制劑tofacitinib治療新冠病毒疫苗引發全身性禿髮症

Alopecia Universalis Induced by COVID-19 Vaccine Treated with JAK inhibitor Tofacitinib

本篇文章尚未正式出版,請點選「收藏」跟進後續出版資訊!

摘要


新冠病毒疫苗施打後引發的疫苗注射反應,一般常見如倦怠、頭痛、腹瀉、注射部位紅腫、發燒和肌肉痠痛,本文以個案報告介紹一種少見的副作用alopecia universalis,藉以探討免疫落髮性疾病(alopecia areata,alopecia totalis,alopecia universalis)的病理機轉,其中部份和JAK-STAT pathway相關,後續用JAK抑制劑(tofacitinib,捷抑炎)治療,得到良好的治療成果。

並列摘要


Common post-COVID-19 vaccine reactions include general malaise, headache, diarrhea, local injection site reaction, fever and myalgia. We present a case report about one kind of rare side effect, alopecia universalis, and discuss the pathophysiology about autoimmune alopecia (alopecia areata, alopecia totalis, alopecia universalis). JAK-STAT pathway plays an important role and we treated the patient with JAK inhibitor tofacitinib which got fair treatment response.

延伸閱讀